drugset / Trial / NCT00200850

Immunotherapy Administered Under the Tongue to Treat Dust Mite Allergy

NCT00200850 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will investigate sublingual immunotherapy (SLIT), a treatment involving antigens placement under the tongue to help asthma sufferers build a tolerance to the allergy-causing substances. Specifically, this study will determine the effectiveness of SLIT at two different dosing regimens for patients with intermittent mild asthma caused by dust mites.

Timeline

Start
2006-01
Primary completion
2008-10
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator House Dust Mite SLIT Vaccine 143 unknown Other
Comparator House Dust Mite SLIT Vaccine 10000 unknown Other

Indications